TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nelin Läkar AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
177
|
117 | |
| Financial expenses |
1
|
0 | |
| Earnings before taxes |
60
|
44 | |
| EBITDA |
67
|
46 | |
| Total assets |
83
|
73 | |
| Current assets |
43
|
43 | |
| Current liabilities |
26
|
29 | |
| Equity capital |
57
|
44 | |
| - share capital |
9
|
9 | |
| Employees (average) |
2
|
0
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
68.7%
|
60.3% | |
| Turnover per employee | 117 | ||
| Profit as a percentage of turnover |
33.9%
|
37.6% | |
| Return on assets (ROA) |
73.5%
|
60.3% | |
| Current ratio |
165.4%
|
148.3% | |
| Return on equity (ROE) |
105.3%
|
100% | |
| Change turnover |
64
|
10 | |
| Change turnover % |
31%
|
56%
|
9% |
| Chg. No. of employees |
2
|
-1
|
0 |
| Chg. No. of employees % |
-100%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.